Síndrome hemolítico-urémico: ciencias básicas.

Same author

Disulfide bond reduction of von Willebrand factor by ADAMTS-13.

Journal of thrombosis and haemostasis : JTH·2010

Same author

Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells.

Journal of thrombosis and haemostasis : JTH·2009

Same author

Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.

Journal of thrombosis and haemostasis : JTH·2008

Same author

Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2006

Same author

Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.

Journal of thrombosis and haemostasis : JTH·2005

Same author

Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.

Journal of thrombosis and haemostasis : JTH·2005

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Síndrome hemolítico-urémico: ciencias básicas.

Videos de Conceptos Relacionados

Disulfide bond reduction of von Willebrand factor by ADAMTS-13.

Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells.

Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.

Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.

Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.

Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Videos de Experimentos Relacionados

Síndrome hemolítico-urémico: ciencias básicas.

Videos de Conceptos Relacionados

Artículos Relacionados

Disulfide bond reduction of von Willebrand factor by ADAMTS-13.

Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells.

Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.

Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.

Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.

Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.